These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 5510856)

  • 1. [Complications involving the eye caused by psychotrophic drugs].
    Gol'dovskaia IL
    Vestn Oftalmol; 1970; 6():54-7. PubMed ID: 5510856
    [No Abstract]   [Full Text] [Related]  

  • 2. [Ophthalmologic study of patients receiving psychotropic drugs].
    Gol'dovskaia IL
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1970 May; 70(5):759-62. PubMed ID: 5311196
    [No Abstract]   [Full Text] [Related]  

  • 3. [Harmful effects of common drugs on the visual apparatus. Psychotropic drugs].
    Hermans G
    Bull Soc Belge Ophtalmol; 1972; 160(1):15-85. PubMed ID: 4403051
    [No Abstract]   [Full Text] [Related]  

  • 4. [Ocular complications in long-term chlorpromazine treatment].
    Klíma M; Klímová A
    Cesk Oftalmol; 1977 Sep; 33(5):349-52. PubMed ID: 922908
    [No Abstract]   [Full Text] [Related]  

  • 5. Orthostatic hypotension and antidepressant pharmacotherapy.
    Tesar GE; Rosenbaum JF; Biederman J; Weilburg JB; Pollack MH; Gross CC; Falk WE; Gastfriend DR; Zusky PM; Bouckoms A
    Psychopharmacol Bull; 1987; 23(1):182-6. PubMed ID: 3602317
    [No Abstract]   [Full Text] [Related]  

  • 6. [Is the combination of antidepressive agents and electroshock under anesthesia dangerous?].
    Porot M; Aillot J; Petit G; Couadau A; Bosson P
    Ann Med Psychol (Paris); 1968 Apr; 1(4):586-91. PubMed ID: 5671923
    [No Abstract]   [Full Text] [Related]  

  • 7. [Prevention and correction of the side effects of psychopharmacologic agents on the eye].
    Gol'dovskaia IL
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1990; 90(2):90-4. PubMed ID: 1971137
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Drug therapy of mental disorders and the eye (review)].
    Gol'dovskaia IL
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1982; 82(3):119-26. PubMed ID: 6123209
    [No Abstract]   [Full Text] [Related]  

  • 9. [The eye and drugs].
    Payrau P
    Eur J Toxicol; 1971; 4(1):60-6. PubMed ID: 4937281
    [No Abstract]   [Full Text] [Related]  

  • 10. [Ocular pathology caused by psychotropic drugs].
    Wharton R; Kilgour W
    Bull Mem Soc Fr Ophtalmol; 1973; 86(0):188-90. PubMed ID: 4794555
    [No Abstract]   [Full Text] [Related]  

  • 11. Ocular complications of chlorpromazine therapy.
    Petrohelos MA; Tricoulis D
    Ophthalmologica; 1969; 158 Suppl():469-76. PubMed ID: 4982681
    [No Abstract]   [Full Text] [Related]  

  • 12. [Irreversible, non-selective monoamine oxidase inhibitors].
    Castberg I; Spigset O
    Tidsskr Nor Laegeforen; 2009 Apr; 129(8):746-8. PubMed ID: 19373300
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Cholestatic hepatitis associated with the use of moclobemide].
    García-Díaz JD; Gila A; Fraguas C; Castillo I
    Med Clin (Barc); 1998 Jun; 111(2):77. PubMed ID: 9706594
    [No Abstract]   [Full Text] [Related]  

  • 14. The use of psychotherapeutic drugs.
    Feder SL
    Med Clin North Am; 1967 Nov; 51(6):1453-66. PubMed ID: 6069546
    [No Abstract]   [Full Text] [Related]  

  • 15. Psychopharmacology column: why choose selegiline transdermal system for refractory depression?
    Tobin M
    Issues Ment Health Nurs; 2007 Feb; 28(2):223-8. PubMed ID: 17365170
    [No Abstract]   [Full Text] [Related]  

  • 16. Sustained effects of phenelzine and tranylcypromine on orthostatic challenge in antidepressant-refractory depression.
    Tulen JH; Volkers AC; van den Broek WW; Bruijn JA
    J Clin Psychopharmacol; 2006 Oct; 26(5):542-4. PubMed ID: 16974207
    [No Abstract]   [Full Text] [Related]  

  • 17. Not all monoamine oxidase inhibitors are created equal.
    Stewart JT
    J Am Geriatr Soc; 2007 Nov; 55(11):1890. PubMed ID: 17979910
    [No Abstract]   [Full Text] [Related]  

  • 18. [Monoamine oxidase inhibitors in psychiatry. Status of current knowledge].
    Volz HP; Gleiter CH; Möller HJ
    Nervenarzt; 1996 May; 67(5):339-47. PubMed ID: 9005342
    [TBL] [Abstract][Full Text] [Related]  

  • 19. What is the bottom line for dietary guidelines when taking monoamine oxidase inhibitors?
    Marcason W
    J Am Diet Assoc; 2005 Jan; 105(1):163. PubMed ID: 15635366
    [No Abstract]   [Full Text] [Related]  

  • 20. [The action spectra of psychopharmacological drugs].
    Poeldinger W
    Clin Ter; 1968 Jan; 44(2):103-13. PubMed ID: 5741268
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.